- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x CA: CALCIUM ION(Non-functional Binders)(Non-covalent)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.3: 6 residues within 4Å:- Chain A: V.183, S.246, R.247, A.248, D.249, K.302
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:R.247, A:R.247, A:D.249
- Water bridges: A:K.302, A:K.302
- Salt bridges: A:K.302
PO4.34: 6 residues within 4Å:- Chain B: V.183, S.246, R.247, A.248, D.249, K.302
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:R.247, B:R.247, B:D.249
- Water bridges: B:K.302, B:K.302
- Salt bridges: B:K.302
- 48 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 5 residues within 4Å:- Chain A: C.152, V.153, L.154, A.155
- Chain B: S.385
Ligand excluded by PLIPACT.5: 7 residues within 4Å:- Chain A: R.327, D.334, R.336, P.337, T.338
- Chain B: R.387
- Ligands: ACT.26
Ligand excluded by PLIPACT.6: 8 residues within 4Å:- Chain A: M.34, G.35, H.159, M.160, G.161
- Chain B: S.388, R.418
- Ligands: ACT.26
Ligand excluded by PLIPACT.7: 7 residues within 4Å:- Chain A: P.21, V.22, L.23, G.24, V.300, R.301
- Ligands: ACT.18
Ligand excluded by PLIPACT.8: 6 residues within 4Å:- Chain A: P.311, V.312
- Chain B: L.48, R.141, D.146
- Ligands: MPD.30
Ligand excluded by PLIPACT.9: 3 residues within 4Å:- Chain A: L.6, S.8, F.283
Ligand excluded by PLIPACT.10: 4 residues within 4Å:- Chain A: L.6, F.283, L.288, R.353
Ligand excluded by PLIPACT.11: 3 residues within 4Å:- Chain A: Q.218
- Chain B: R.31, D.32
Ligand excluded by PLIPACT.12: 6 residues within 4Å:- Chain A: E.26, R.36, K.180, F.181, V.183, P.223
Ligand excluded by PLIPACT.13: 4 residues within 4Å:- Chain A: T.25, E.26, I.27, E.177
Ligand excluded by PLIPACT.14: 7 residues within 4Å:- Chain A: E.18, M.19, T.20, P.21, V.22, R.301, K.328
Ligand excluded by PLIPACT.15: 3 residues within 4Å:- Chain A: N.195, E.197
- Chain B: R.31
Ligand excluded by PLIPACT.16: 4 residues within 4Å:- Chain A: D.296, I.297, D.298, G.299
Ligand excluded by PLIPACT.17: 4 residues within 4Å:- Chain A: T.25, A.39, K.156, N.179
Ligand excluded by PLIPACT.18: 5 residues within 4Å:- Chain A: D.296, G.299, V.300, R.301
- Ligands: ACT.7
Ligand excluded by PLIPACT.19: 5 residues within 4Å:- Chain A: R.343, H.406, K.407, G.408, E.409
Ligand excluded by PLIPACT.20: 8 residues within 4Å:- Chain A: E.75, S.76, Q.77, E.80, P.82, T.83, Q.84, M.92
Ligand excluded by PLIPACT.21: 4 residues within 4Å:- Chain A: D.69, R.70, F.71, G.89
Ligand excluded by PLIPACT.22: 8 residues within 4Å:- Chain A: P.52, I.100, P.101, C.102, G.103, A.104, D.105, I.140
Ligand excluded by PLIPACT.23: 4 residues within 4Å:- Chain A: L.227, V.230, A.240, E.243
Ligand excluded by PLIPACT.24: 4 residues within 4Å:- Chain A: L.17, D.334, P.335, R.336
Ligand excluded by PLIPACT.25: 4 residues within 4Å:- Chain A: K.341, V.410, V.411, D.412
Ligand excluded by PLIPACT.26: 7 residues within 4Å:- Chain A: H.159, R.327, I.332
- Chain B: R.387, S.388
- Ligands: ACT.5, ACT.6
Ligand excluded by PLIPACT.27: 4 residues within 4Å:- Chain A: K.56, Q.109, Q.138, D.139
Ligand excluded by PLIPACT.35: 5 residues within 4Å:- Chain A: S.385
- Chain B: C.152, V.153, L.154, A.155
Ligand excluded by PLIPACT.36: 7 residues within 4Å:- Chain A: R.387
- Chain B: R.327, D.334, R.336, P.337, T.338
- Ligands: ACT.57
Ligand excluded by PLIPACT.37: 8 residues within 4Å:- Chain A: S.388, R.418
- Chain B: M.34, G.35, H.159, M.160, G.161
- Ligands: ACT.57
Ligand excluded by PLIPACT.38: 7 residues within 4Å:- Chain B: P.21, V.22, L.23, G.24, V.300, R.301
- Ligands: ACT.49
Ligand excluded by PLIPACT.39: 6 residues within 4Å:- Chain A: L.48, R.141, D.146
- Chain B: P.311, V.312
- Ligands: MPD.61
Ligand excluded by PLIPACT.40: 3 residues within 4Å:- Chain B: L.6, S.8, F.283
Ligand excluded by PLIPACT.41: 4 residues within 4Å:- Chain B: L.6, F.283, L.288, R.353
Ligand excluded by PLIPACT.42: 3 residues within 4Å:- Chain A: R.31, D.32
- Chain B: Q.218
Ligand excluded by PLIPACT.43: 6 residues within 4Å:- Chain B: E.26, R.36, K.180, F.181, V.183, P.223
Ligand excluded by PLIPACT.44: 4 residues within 4Å:- Chain B: T.25, E.26, I.27, E.177
Ligand excluded by PLIPACT.45: 7 residues within 4Å:- Chain B: E.18, M.19, T.20, P.21, V.22, R.301, K.328
Ligand excluded by PLIPACT.46: 3 residues within 4Å:- Chain A: R.31
- Chain B: N.195, E.197
Ligand excluded by PLIPACT.47: 4 residues within 4Å:- Chain B: D.296, I.297, D.298, G.299
Ligand excluded by PLIPACT.48: 4 residues within 4Å:- Chain B: T.25, A.39, K.156, N.179
Ligand excluded by PLIPACT.49: 5 residues within 4Å:- Chain B: D.296, G.299, V.300, R.301
- Ligands: ACT.38
Ligand excluded by PLIPACT.50: 5 residues within 4Å:- Chain B: R.343, H.406, K.407, G.408, E.409
Ligand excluded by PLIPACT.51: 8 residues within 4Å:- Chain B: E.75, S.76, Q.77, E.80, P.82, T.83, Q.84, M.92
Ligand excluded by PLIPACT.52: 4 residues within 4Å:- Chain B: D.69, R.70, F.71, G.89
Ligand excluded by PLIPACT.53: 8 residues within 4Å:- Chain B: P.52, I.100, P.101, C.102, G.103, A.104, D.105, I.140
Ligand excluded by PLIPACT.54: 4 residues within 4Å:- Chain B: L.227, V.230, A.240, E.243
Ligand excluded by PLIPACT.55: 4 residues within 4Å:- Chain B: L.17, D.334, P.335, R.336
Ligand excluded by PLIPACT.56: 4 residues within 4Å:- Chain B: K.341, V.410, V.411, D.412
Ligand excluded by PLIPACT.57: 7 residues within 4Å:- Chain A: R.387, S.388
- Chain B: H.159, R.327, I.332
- Ligands: ACT.36, ACT.37
Ligand excluded by PLIPACT.58: 4 residues within 4Å:- Chain B: K.56, Q.109, Q.138, D.139
Ligand excluded by PLIP- 2 x NA: SODIUM ION(Non-functional Binders)
NA.28: 7 residues within 4Å:- Chain A: P.286, G.287, L.288, P.289, P.308, N.310, S.313
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:G.287, A:S.313, A:S.313
- Water bridges: A:L.288
NA.59: 7 residues within 4Å:- Chain B: P.286, G.287, L.288, P.289, P.308, N.310, S.313
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.287, B:S.313
- Water bridges: B:L.288
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.29: 26 residues within 4Å:- Chain A: S.188, T.189, E.192, L.193, I.205, R.206, D.207, S.208, N.209, R.210, S.254, G.255, G.256, V.257, S.258, D.263, P.289, P.308, G.309, N.310, P.311
- Chain B: T.96, G.97, R.141
- Ligands: CA.1, CA.2
23 PLIP interactions:17 interactions with chain A, 6 interactions with chain B- Hydrogen bonds: A:S.188, A:D.207, A:D.207, A:S.208, A:S.208, A:N.209, A:G.256, A:V.257, A:S.258, A:S.258, A:S.258, A:G.309, B:R.141
- Water bridges: A:E.192, A:E.192, A:N.209, A:N.209, A:N.310, B:T.96, B:T.96, B:T.96, B:G.97, B:G.97
ADP.60: 26 residues within 4Å:- Chain A: T.96, G.97, R.141
- Chain B: S.188, T.189, E.192, L.193, I.205, R.206, D.207, S.208, N.209, R.210, S.254, G.255, G.256, V.257, S.258, D.263, P.289, P.308, G.309, N.310, P.311
- Ligands: CA.32, CA.33
24 PLIP interactions:18 interactions with chain B, 6 interactions with chain A- Hydrogen bonds: B:S.188, B:E.192, B:D.207, B:S.208, B:S.208, B:N.209, B:G.256, B:V.257, B:S.258, B:S.258, B:S.258, B:G.309, A:R.141
- Water bridges: B:E.192, B:E.192, B:N.209, B:N.209, B:D.263, B:N.310, A:T.96, A:T.96, A:T.96, A:G.97, A:G.97
- 2 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.30: 13 residues within 4Å:- Chain A: S.208, T.212, P.311, V.312, V.315, R.358
- Chain B: L.48, I.147, S.163, G.166, L.167, T.170
- Ligands: ACT.8
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:T.212, A:P.311, A:V.312, B:L.167
- Hydrogen bonds: A:R.358, A:R.358
- Water bridges: A:S.208
MPD.61: 13 residues within 4Å:- Chain A: L.48, I.147, S.163, G.166, L.167, T.170
- Chain B: S.208, T.212, P.311, V.312, V.315, R.358
- Ligands: ACT.39
7 PLIP interactions:6 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:T.212, B:P.311, B:V.312, A:L.167
- Hydrogen bonds: B:R.358, B:R.358
- Water bridges: B:S.208
- 2 x D8Z: Artemether(Non-covalent)
D8Z.31: 12 residues within 4Å:- Chain A: M.9, D.10, F.13, I.14, L.320, P.324, R.336, P.337, I.339, Y.356, M.394, M.414
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.13, A:F.13, A:F.13, A:P.337, A:I.339, A:I.339
D8Z.62: 12 residues within 4Å:- Chain B: M.9, D.10, F.13, I.14, L.320, P.324, R.336, P.337, I.339, Y.356, M.394, M.414
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:F.13, B:F.13, B:F.13, B:P.337, B:I.339, B:I.339
- Hydrogen bonds: B:D.10
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kasaragod, V.B. et al., Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins. Neuron (2019)
- Release Date
- 2019-01-16
- Peptides
- Gephyrin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x CA: CALCIUM ION(Non-functional Binders)(Non-covalent)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- 48 x ACT: ACETATE ION(Non-functional Binders)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- 2 x D8Z: Artemether(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kasaragod, V.B. et al., Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins. Neuron (2019)
- Release Date
- 2019-01-16
- Peptides
- Gephyrin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A